AB 2250: Cannabis: cannabinoids.

Official summary

Legislative Counsel’s Digest (official, as of the latest version). Written by nonpartisan legislative staff; reproduced verbatim.

Chapter 248 of the Statutes of 2025 (AB 8) revised the Sherman Food, Drug, and Cosmetic Law to prohibit industrial hemp raw extract from being incorporated into food, food additives, beverages, or dietary supplements unless the industrial hemp raw extract is comprised of cannabidiol (CBD) or cannabinol (CBN) isolate with a purity level greater than 99% and does not contain any tetrahydrocannabinols or synthetic cannabinoids. AB 8, beginning January 1, 2028, revises and recasts various provisions in conformity with that prohibition. Among those conforming changes, AB 8 excludes CBD isolate from the definition of “cannabis concentrate” for purposes of the California Uniform Controlled Substances Act, which imposes various penalties for the unlawful possession or sale of cannabis concentrate.

This bill, beginning on January 1, 2028, would also exclude CBN isolate from that definition of “cannabis concentrate.”

AB 8 revised certain Cannabis Tax Law enforcement provisions by establishing a presumption that a product that contains or purports to contain a cannabinoid is a cannabis product, as specified. AB 8 authorized this presumption to be rebutted by evidence showing either that the product complies with the Sherman Food, Drug, and Cosmetic Law provisions regulating industrial hemp or that it meets the definition of industrial hemp as defined in the California Uniform Controlled Substances Act.

This bill would make organizational and clarifying changes to those presumption provisions. The bill would consolidate and make other clarifying changes to definitional provisions of the Cannabis Tax Law revised by AB 8.

The Cannabis Tax Law authorizes the California Department of Tax and Fee Administration or a law enforcement agency to seize cannabis or cannabis products from a person who possesses, stores, owns, or has made a sale of those cannabis or cannabis products under certain circumstances. AB 8 expanded the seizure authority under the Cannabis Tax Law to include a circumstance in which the product is possessed, stored, offered for sale, or sold by an unlicensed person or at an unlicensed premises, and is presumed to be a cannabis product for containing or purporting to contain a cannabinoid, including a synthetic cannabinoid, as defined.

This bill would remove that AB 8 provision and, instead, would expand that seizure authority to include a circumstance in which the cannabis or cannabis product is possessed, stored, offered for sale, or sold at an unlicensed premises.

Sponsors

Sponsors by party (alphabetical): Democratic 1

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

1. September 27, 2026Chaptered by Secretary of State - Chapter 593, Statutes of 2026.
2. September 27, 2026Approved by the Governor.
3. September 3, 2026Enrolled and presented to the Governor at 4 p.m.
4. August 26, 2026Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 78. Noes 0. Page 6581.).
5. August 25, 2026In Assembly. Concurrence in Senate amendments pending.
6. August 25, 2026Read third time. Passed. Ordered to the Assembly. (Ayes 38. Noes 0.).
7. August 24, 2026Read second time. Ordered to third reading.
8. August 21, 2026Read third time and amended. Ordered to second reading.
9. August 13, 2026Read second time. Ordered to third reading.
10. August 13, 2026From committee: Do pass. (Ayes 7. Noes 0.) (August 13).
11. August 3, 2026In committee: Referred to APPR. suspense file.
12. June 24, 2026From committee: Do pass and re-refer to Com. on APPR. (Ayes 4. Noes 0.) (June 24). Re-referred to Com. on APPR.